Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Akashi

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Biological & Pharmaceutical Bulletin|November 1, 1994
Antihypertensive effects of a novel calcium antagonist, semotiadil fumarate (SD-3211), alone and in combination with enalapril or trichlormethiazide in spontaneously hypertensive ratsM Ichikawa, M Wanaka, T Ohtsuji, et al.
International Journal of Cancer|March 10, 2001
Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapyS Akashi-Tanaka, T Fukutomi, T Watanabe, et al.
Breast Cancer (Tokyo, Japan)|October 23, 2000
Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastasesH Higashi, T Fukutomi, T Watanabe, et al.
Breast Cancer (Tokyo, Japan)|October 23, 2001
Two special types of breast cancer presenting as progressive disease after neoadjuvant chemotherapy with docetaxel plus doxorubicinT Takahashi, S Akashi-Tanaka, T Fukutomi, et al.
British Journal of Cancer|August 4, 2011
Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breastT Hasebe, M Iwasaki, S Akashi-Tanaka, et al.
Japanese Journal of Clinical Oncology|March 10, 1998
Breast cancer in Cowden's disease: a case report with review of the literatureY Tsubosa, T Fukutomi, H Tsuda, et al.
Oncogene|July 14, 2015
Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironmentA Deguchi, T Tomita, U Ohto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expressionK Miyake, R Shimazu, J Kondo, et al.
The Journal of Experimental Medicine|July 6, 2000
The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cellsH Ogata, I Su, K Miyake, et al.
Infection and Immunity|March 20, 2001
Micrococcus luteus teichuronic acids activate human and murine monocytic cells in a CD14- and toll-like receptor 4-dependent mannerS Yang, S Sugawara, T Monodane, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Biological & Pharmaceutical Bulletin|November 1, 1994
Antihypertensive effects of a novel calcium antagonist, semotiadil fumarate (SD-3211), alone and in combination with enalapril or trichlormethiazide in spontaneously hypertensive ratsM Ichikawa, M Wanaka, T Ohtsuji, et al.
International Journal of Cancer|March 10, 2001
Accuracy of contrast-enhanced computed tomography in the prediction of residual breast cancer after neoadjuvant chemotherapyS Akashi-Tanaka, T Fukutomi, T Watanabe, et al.
Breast Cancer (Tokyo, Japan)|October 23, 2000
Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastasesH Higashi, T Fukutomi, T Watanabe, et al.
Breast Cancer (Tokyo, Japan)|October 23, 2001
Two special types of breast cancer presenting as progressive disease after neoadjuvant chemotherapy with docetaxel plus doxorubicinT Takahashi, S Akashi-Tanaka, T Fukutomi, et al.
British Journal of Cancer|August 4, 2011
Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breastT Hasebe, M Iwasaki, S Akashi-Tanaka, et al.
Japanese Journal of Clinical Oncology|March 10, 1998
Breast cancer in Cowden's disease: a case report with review of the literatureY Tsubosa, T Fukutomi, H Tsuda, et al.
Oncogene|July 14, 2015
Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironmentA Deguchi, T Tomita, U Ohto, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expressionK Miyake, R Shimazu, J Kondo, et al.
The Journal of Experimental Medicine|July 6, 2000
The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cellsH Ogata, I Su, K Miyake, et al.
Infection and Immunity|March 20, 2001
Micrococcus luteus teichuronic acids activate human and murine monocytic cells in a CD14- and toll-like receptor 4-dependent mannerS Yang, S Sugawara, T Monodane, et al.
Pageof 9